- Home
- MTZ vs NBIX Comparison
MTZ vs NBIX Comparison
Compare MTZ & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTZ
- NBIX
- Stock Information
- Founded
- MTZ 1929
- NBIX 1992
- Country
- MTZ United States
- NBIX United States
- Employees
- MTZ N/A
- NBIX N/A
- Industry
- MTZ Water Sewer Pipeline Comm & Power Line Construction
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTZ Industrials
- NBIX Health Care
- Exchange
- MTZ Nasdaq
- NBIX Nasdaq
- Market Cap
- MTZ 13.6B
- NBIX 14.4B
- IPO Year
- MTZ N/A
- NBIX 1996
- Fundamental
- Price
- MTZ $199.43
- NBIX $146.35
- Analyst Decision
- MTZ Strong Buy
- NBIX Strong Buy
- Analyst Count
- MTZ 22
- NBIX 18
- Target Price
- MTZ $221.86
- NBIX $172.33
- AVG Volume (30 Days)
- MTZ 1.0M
- NBIX 1.1M
- Earning Date
- MTZ 10-30-2025
- NBIX 10-28-2025
- Dividend Yield
- MTZ N/A
- NBIX N/A
- EPS Growth
- MTZ 270.77
- NBIX 12.44
- EPS
- MTZ 4.20
- NBIX 4.19
- Revenue
- MTZ $13,762,473,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- MTZ $15.02
- NBIX $23.68
- Revenue Next Year
- MTZ $9.93
- NBIX $18.02
- P/E Ratio
- MTZ $47.89
- NBIX $35.13
- Revenue Growth
- MTZ 12.99
- NBIX 19.61
- 52 Week Low
- MTZ $99.70
- NBIX $84.23
- 52 Week High
- MTZ $224.03
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- MTZ 45.77
- NBIX 52.51
- Support Level
- MTZ $195.00
- NBIX $145.00
- Resistance Level
- MTZ $207.94
- NBIX $157.67
- Average True Range (ATR)
- MTZ 8.41
- NBIX 5.14
- MACD
- MTZ -1.35
- NBIX 0.23
- Stochastic Oscillator
- MTZ 30.63
- NBIX 51.35
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.